Change in the second exteroceptive suppression period of the temporalis muscle during erenumab treatment.
Sign Up to like & getrecommendations! Published in 2022 at "Naunyn-Schmiedeberg's archives of pharmacology"
DOI: 10.1007/s00210-022-02216-4
Abstract: Comparative studies on the second exteroceptive suppression period (ES2) of the masseter or temporalis muscle in migraineurs and controls have provided conflicting results. As the interneurons responsible for ES2 are probably close to the trigeminal… read more here.
Keywords: exteroceptive suppression; treatment; erenumab treatment; temporalis muscle ... See more keywords